Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

View 0 Studies Requested

Browse Lab Results > 2020-0003

Trial Summary

About CDAS Project, PI, Publications: Serum levels of per- and polyfluorinated substances and risks of non-Hodgkin lymphoma and thyroid cancer

Datasets


Site: Lymphoid

Inclusion Criteria:

  • No Rare Cancers
  • Remove Hema Cases not of Interest
  • Has Serum
  • Has 250ul Pre-DX Serum (Eligible)
  • Matched at a 2-1 Ratio for Thyroid and a 1-1 Ratio For Hematopoietic (Selected)

Matching Factors:

  • Gender
  • Race (W/B/O)
  • Center for Hema match
  • Grouped study year of material (T0, T1/T2, T4/T5)
  • Calendar Year of Draw +/- 1 year
  • Age at Draw +/- 3 years

Match Ratio: 2-1 for Thyroid; 1-1 for Hematopoietic

Match Technique: Frequency matching only non-cases as controls.

Additional Matching Comments: The Hema match was done first and then the thyroid match was done targeting controls selected for the hema cases.


Analytes:

  • PFDA
  • PFHpA
  • PFHpS
  • PFHxA
  • PFHxS
  • PFNA
  • PFOA
  • PFOS branched
  • PFOS linear
  • PFOS total
  • PFUnA

Number of Cases: 894

Number of Controls: 761